The management of hyperkalaemia in primary care - free webinar

Join us for a free webinar for UK healthcare professionals on the management of hyperkalaemia in primary care on 29 November 2022.

This MIMS Learning webinar, organised and funded by AstraZeneca, aims to review the current management approach to persistent hyperkalaemia for patients with chronic kidney disease and heart failure and highlights the role of primary care in the management of these patients.

Tuesday 29 November 2022 19:00 GMT
Register now


This promotional webinar is organised and funded by AstraZeneca and is intended for UK healthcare professionals only. It contains promotional information on AstraZeneca products. Prescribing information is available at the links below.

LOKELMA® (sodium zirconium cyclosilicate) is indicated for the treatment of hyperkalaemia in adult patients.

Click here for Great Britain prescribing information for LOKELMA® (sodium zirconium cyclosilicate).
Click here for Northern Ireland prescribing information for LOKELMA® (sodium zirconium cyclosilicate).

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.

GB-38550; October 2022

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

An empty tablet blister pack.

Ezetimibe supply update

Availability issues have been reported for the lipid-lowering...

Woman holding blister strip of contraceptive pills

Pharmacists across England to initiate oral contraceptives

Pharmacy Contraception Service (PCS) could allow almost...